Tag: ANDA
Pharmaceutical Patents, Settlements, Reverse Payments, and Exclusion
John Bigelow, Jun 27, 2012
Cases involving pharmaceuticals settlements to patent litigation with so called "reverse payments" or, as the FTC now prefers to call...
Cervantes Sequel: The FTC’s Quest to End Pay-for-Delay Pharma Settlements
Anne Layne-Farrar, Jun 27, 2012
We are drawing close to the thirtieth anniversary of the Drug Price Competition and Patent Term Restoration Act, better known...
Reverse Payment Settlements: Presumptively Bad or Usually Acceptable?
Kyle Musgrove, Richard Ripley, Jun 27, 2012
In April 2012, the Federal Trade Commission ("FTC") suffered yet another rebuke of what FTC Chair Jon Leibowitz...
Federal Trade Commission Rejected in “Reverse Payment” Suit
Kevin Noonan, Jun 27, 2012
The Federal Trade Commission in recent years has identified a practice it considers to be a threat to consumers regarding...
